Epidemiological determinants and clinical profile of eclampsia: a case control study

Ritam De; Amit Dutta

doi:10.18203/2320-1770.ijrcog20191213

Authors

Ritam De Department of Obstetrics and Gynecology, Gouri Devi Institute of Medical Sciences and Hospital, Durgapur, West Bengal, India
Amit Dutta Department of Obstetrics and Gynecology, Gouri Devi Institute of Medical Sciences and Hospital, Durgapur, West Bengal, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20191213

Keywords:

Eclampsia, Epidemiological determinants, Outcomes, Pregnancy, Risk factors

Abstract

Background: The incidence of eclampsia has reduced considerably in the developing countries due to good antenatal care and increased awareness within the population. To determine the magnitude of the problem, to assess trends and to identify risk factors and risk groups, it is worthwhile to periodically review this problem.

Methods: A study using one control for each case of eclampsia was conducted among women who were admitted at Burdwan Medical College and Hospital between July 2014 and June 2015. Cases were women with a confirmed diagnosis of eclampsia. Eclampsia cases were identified by daily monitoring of all new admissions to Eclampsia ward of Burdwan Medical College and hospital. After strict exclusion criteria, a total of 500 eclampsia cases were studied along with same number of controls for identifying the epidemiological determinants.

Results: Maternal age at extremes (<20 and >30 years) was identified as a risk factor of eclampsia. Nulliparity has been identified as a risk factor for eclampsia in present study. About 74.6% mothers were nulliparous. Most of the patients 66.6% were admitted during the antenatal period i.e. presented with antenatal eclampsia. 62.2% of them were at between 34-37weeks of gestational age during admission.

Conclusions: Authors observed increased eclampsia risk among women with a prior history of pregnancies complicated by hypertensive disorders. Positive personal histories of hypertensive disorders of pregnancy and family history of hypertensive disorders are well known risk factors of eclampsia. Our findings point to public health and clinical measures that may be taken to potentially attenuate the incidence of eclampsia and mitigate associated maternal-fetal complications resulting from the disorder.

Metrics

Metrics Loading ...

References

Duley L, Matar HE, Almerie MQ, Hall DR. Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia. Cochrane Database Syst Rev 2010(8):CD007388.

Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean, Br J Obstet Gynaecol 1992;99(7):547-53.

Barua A, Mundle S, Bracken H, Easterling T, Winikoff B. Facility and personnel factors influencing magnesium sulphate use for eclampsia and pre-eclampsia in 3 Indian hospitals. Int J Gynecol Obstet. 2011;115(3):231-4.

World Health Organisation International Collaborative Study of Hypertensive Disorders of pregnancy.Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol 1988; 158(1):80-3.

Swain S, Ojha KN, Prakash A, Bhatia BD. Maternal and perinatal mortality due to eclampsia. Indian Pediat. 1993;30(6):771-3.

Walker JJ. Modern management of pre-eclampsia and eclampsia in recent advances in Obstetric and Gynaecology, Vol-3, Ed. Dasgupta,New Delhi,Jypee brothers,1997:P78-97.

Menon MKK, Devi PK, Rao KB. Postgraduate Obstetrics and Gynaecology, 4th Edn, Madras (Chennai): 1989: P-52.

Chelbi ST, Vaiman D. Genetic and epigenetic factors contribute to the onset of preeclampsia. Molecular Cell Endocrinol. 2008;282(1-2):120-9.

Chakraborty B, Dasgupta S. How much Magsulph in eclampsia? - A prospective trial on low dose regime, Indian J Perinatol Reprod Bio 2011;1(5):14-6.

Al-Mulhim AA, Abu-Heija A, Al-Jamma F, El-Harith EH. Pre-eclampsia: maternal risk factors and perinatal outcome. Fetal Diagnos Therap. 2003;18(4):275-80.

Conde‐Agudelo A, Belizán JM. Risk factors for pre‐eclampsia in a large cohort of Latin American and Caribbean women. BJOG: Int J Obstet Gynaecol. 2000;107(1):75-83.

Pal B, Niyogi G, Patkar V. A study of eclampsia. J Obstet Gynecol Ind 1996;56:34.

Majhi AK. Eclampsia-present scenerio in a referral medical college hospital. J Obstet Gynaecol India. 2001;51:143-7.

Stone JL. Lockwood cJ, Berkowitz GS, Alvarez M, Lapinski R, Berkowitz RL. Risk factors for severe preeclampsia. Obstet. Gynecol. 1994;83:357-61.

Sanchez SE, Qiu C, Williams MA, Lam N, Sorensen TK. Headaches and migraines are associated with an increased risk of preeclampsia in Peruvian women. Am J Hypertens. 2008;21(3):360-4.

Ogbonna C, Woelk GB, Ning Y, Mudzamiri S, Mahomed K, Williams MA. Maternal mid-arm circumference and other anthropometric measures of adiposity in relation to infant birth size among Zimbabwean women. Acta Obstetricia et Gynecologica Scandinavica. 2007 ;86(1):26-32.

Mittendorf R, Lain KY, Williams MA, Walker CK. Preeclampsia. A nested, case-control study of risk factors and their interactions. J Reproduct Med. 1996;41(7):491-6.

Mostello D, Kallogjeri D, Tungsiripat R, Leet T. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. Am J Obstet Gynecol. 2008;199(1):55-e1.

Ananth CV, Peltier MR, Chavez MR, Kirby RS, Getahun D, Vintzileos AM. Recurrence of ischemic placental disease. Obstetrics Gynecol. 2007;110(1):128-33.

Ødegård RA, Vatten LJ, Nilsen ST, Salvesen KÅ, Austgulen R. Risk factors and clinical manifestations of pre‐eclampsia. BJOG: Int J Obstet Gynaecol. 2000;107(11):1410-6.

Sibai B. Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365:785-99.

Royal College of Obstetricians and Gynecologists. The management of severe pre-eclampsia/eclampsia. Evidence Based Clinical Guideline No 10(A). London: RCOG Press; 2006, Reviewed in 2010.